DekaBank Deutsche Girozentrale
CBIO

DekaBank Deutsche Girozentrale’s Crescent Biopharma CBIO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-218
Closed -$251K – 1044
2019
Q2 		$251K Buy
218
+84
+63% +$100K ﹤0.01% 994
2019
Q1 		$200K Buy
134
+25
+23% +$28.6K ﹤0.01% 1042
2018
Q4 		$95K Sell
109
-25
-19% -$30.1K ﹤0.01% 1065
2018
Q3 		$200K Sell
134
-3
-2% -$4.54K ﹤0.01% 1063
2018
Q2 		$216K Hold
137
– – ﹤0.01% 1035
2018
Q1 		$220K Buy
+137
New +$285K ﹤0.01% 982

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return